Common Stock, Shares, Outstanding of INTERCEPT PHARMACEUTICALS, INC. from 31 Dec 2011 to 30 Sep 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2011 to 30 Sep 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2023 was 41,811,686, a 0.95% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 41,811,686 +394,559 +0.95% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 41,782,727 +11,984,687 +40% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 41,687,084 +11,978,238 +40% 31 Mar 2023 10-Q 27 Apr 2023 2023 Q1
Q4 2022 41,523,337 +11,950,384 +40% 31 Dec 2022 10-Q 06 Nov 2023 2023 Q3
Q3 2022 41,417,127 +11,870,153 +40% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 29,798,040 -3,403,141 -10% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 29,708,846 -3,445,261 -10% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 29,572,953 -3,442,661 -10% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 29,546,974 -3,445,462 -10% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 33,201,181 +220,377 +0.67% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 33,154,107 +216,676 +0.66% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 33,015,614 +162,548 +0.5% 31 Dec 2020 10-K 02 Mar 2022 2021 FY
Q3 2020 32,992,436 +258,989 +0.79% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 32,980,804 +284,420 +0.87% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 32,937,431 +3,160,353 +11% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 32,853,066 +3,159,190 +11% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 32,733,447 +3,078,979 +10% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 32,696,384 +3,131,700 +11% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 29,777,078 +4,445,270 +18% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 29,693,876 +4,521,198 +18% 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q3 2018 29,654,468 +4,552,389 +18% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 29,564,684 +4,464,763 +18% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 25,331,808 +319,634 +1.3% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 25,172,678 +352,760 +1.4% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 25,102,079 +311,127 +1.3% 30 Sep 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 25,099,921 +423,992 +1.7% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 25,012,174 +418,149 +1.7% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 24,819,918 +428,488 +1.8% 31 Dec 2016 10-K 28 Feb 2018 2017 FY
Q3 2016 24,790,952 +535,760 +2.2% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 24,675,929 +526,688 +2.2% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 24,594,025 +1,887,052 +8.3% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 24,391,430 +2,976,187 +14% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 24,255,192 +2,931,643 +14% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 24,149,241 +2,970,499 +14% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 22,706,973 +3,140,333 +16% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 21,415,243 +2,025,633 +10% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 21,323,549 +2,022,592 +10% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 21,178,742 +2,139,087 +11% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 19,566,640 +2,932,676 +18% 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 19,389,610 +2,862,725 +17% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 19,300,957 +15,971,291 +480% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 19,039,655 30 Jun 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 16,633,964 31 Mar 2013 10-Q 14 May 2013 2013 Q1
Q4 2012 16,526,885 +13,197,219 +396% 31 Dec 2012 10-Q 14 Nov 2013 2013 Q3
Q3 2012 3,329,666 30 Sep 2012 10-Q/A 21 Dec 2012 2012 Q3
Q4 2011 3,329,666 31 Dec 2011 10-K 01 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.